000			02032 a2200565 4500
005			20250516225156.0
264		0	_c20150722
008			201507s 0 0 eng d
022			_a1476-5608
024	7		_a10.1038/pcan.2014.28 _2doi
040			_aNLM _beng _cNLM
100	1		_aMcKay, R R
245	0	0	_aImaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. _h[electronic resource]
260			_bProstate cancer and prostatic diseases _cDec 2014
300			_a325-31 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAndrogen Antagonists _xtherapeutic use
650	0	4	_aAndrostenes _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAzasteroids _xadministration & dosage
650	0	4	_aBiopsy _xmethods
650	0	4	_aBone Neoplasms _xdiagnostic imaging
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aDutasteride
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProstatic Neoplasms, Castration-Resistant _xdiagnostic imaging
650	0	4	_aRadiography, Interventional _xmethods
650	0	4	_aRadionuclide Imaging
650	0	4	_aRadiopharmaceuticals
650	0	4	_aSurgery, Computer-Assisted _xmethods
650	0	4	_aTechnetium Tc 99m Medronate
700	1		_aZukotynski, K A
700	1		_aWerner, L
700	1		_aVoznesensky, O
700	1		_aWu, J S
700	1		_aSmith, S E
700	1		_aJiang, Z
700	1		_aMelnick, K
700	1		_aYuan, X
700	1		_aKantoff, P W
700	1		_aMontgomery, B
700	1		_aBalk, S P
700	1		_aTaplin, M-E
773	0		_tProstate cancer and prostatic diseases _gvol. 17 _gno. 4 _gp. 325-31
856	4	0	_uhttps://doi.org/10.1038/pcan.2014.28 _zAvailable from publisher's website
999			_c24069316 _d24069316